» Articles » PMID: 14678060

Shape of the Relapse Curve and Long-term Abstinence Among Untreated Smokers

Overview
Journal Addiction
Specialty Psychiatry
Date 2003 Dec 18
PMID 14678060
Citations 594
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the relapse curve and rate of long-term prolonged abstinence among smokers who try to quit without treatment.

Method: Systematic literature review.

Data Sources: Cochrane Reviews, Dissertation Abstracts, Excerpt Medica, Medline, Psych Abstracts and US Center for Disease Control databases plus bibliographies of articles and requests of scientists.

Study Selection: Prospective studies of self-quitters or studies that included a no-treatment control group.

Data Extraction: Two reviewers independently extracted data in a non-blind manner.

Data Synthesis: The number of studies was too small and the data too heterogeneous for meta-analysis or other statistical techniques.

Results: There is a paucity of studies reporting relapse curves of self-quitters. The existing eight relapse curves from two studies of self-quitters and five no-treatment control groups indicate most relapse occurs in the first 8 days. These relapse curves were heterogeneous even when the final outcome was made similar. In terms of prolonged abstinence rates, a prior summary of 10 self-quitting studies, two other studies of self-quitters and three no-treatment control groups indicate 3-5% of self-quitters achieve prolonged abstinence for 6-12 month after a given quit attempt.

Conclusions: More reports of relapse curves of self-quitters are needed. Smoking cessation interventions should focus on the first week of abstinence. Interventions that produce abstinence rates of 5-10% may be effective. Cessation studies should report relapse curves.

Citing Articles

Usability of a digital mindfulness training program for smoking cessation: A mixed-method single-center pilot study protocol (HowToMind).

Demina A, Soudry-Faure A, Petit B, Meunier-Beillard N, Trojak B PLoS One. 2025; 20(2):e0318686.

PMID: 39977412 PMC: 11841885. DOI: 10.1371/journal.pone.0318686.


Cytisine for smoking cessation in hospitalised smokers with cardiovascular diseases: an observational study.

Erika T, Sofia C, Alessandro T, Laura S, Lorenzo L, Andrea B Intern Emerg Med. 2025; .

PMID: 39939444 DOI: 10.1007/s11739-025-03888-5.


Electronic cigarettes for smoking cessation.

Lindson N, Butler A, McRobbie H, Bullen C, Hajek P, Wu A Cochrane Database Syst Rev. 2025; 1:CD010216.

PMID: 39878158 PMC: 11776059. DOI: 10.1002/14651858.CD010216.pub9.


Prevalence of Popular Smoking Cessation Aids in England and Associations With Quit Success.

Jackson S, Brown J, Buss V, Shahab L JAMA Netw Open. 2025; 8(1):e2454962.

PMID: 39821398 PMC: 11742533. DOI: 10.1001/jamanetworkopen.2024.54962.


Exploring the therapeutic potential of tDCS, TMS and DBS in overcoming tobacco use disorder: an umbrella review.

Orru G, Baroni M, Conversano C, Gemignani A AIMS Neurosci. 2025; 11(4):449-467.

PMID: 39801797 PMC: 11712234. DOI: 10.3934/Neuroscience.2024027.